Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.76
-0.0100-0.36%
Post-market: 2.760.00000.00%17:19 EST
Volume:98.16K
Turnover:272.63K
Market Cap:11.70M
PE:-0.27
High:2.90
Open:2.81
Low:2.64
Close:2.77
52wk High:20.59
52wk Low:2.45
Shares:4.24M
Float Shares:4.06M
Volume Ratio:1.75
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.3401
EPS(LYR):-41.8902
ROE:-145.42%
ROA:-72.31%
PB:1.57
PE(LYR):-0.07

Loading ...

May 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

Form 8-K - Current report
Mar 16, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2023

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 23, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 25, 2022

Major Issues Report

8-K - Current report
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]